Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).
Shanghai Pharmaceuticals Holding Co., Ltd. has announced the convening of an Extraordinary General Meeting on December 9, 2025, due to insufficient shareholder voting shares to meet the required threshold. This meeting will address key matters as outlined in the company’s notice and circular, potentially impacting the company’s governance and strategic decisions.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the development, manufacturing, and distribution of pharmaceutical products, focusing on both domestic and international markets.
Average Trading Volume: 3,224,714
Technical Sentiment Signal: Buy
Current Market Cap: HK$65.65B
For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.